Avalo Therapeutics CFO Christopher Ryan Sullivan disposes of 12,394 common shares for $202,436.79
Bitget2026/09/18 20:10Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Avalo Therapeutics CFO Christopher Ryan Sullivan sold 12,394 common shares at USD 16.33 on Sep. 16, 2026.
- Sale followed the exercise of stock options for 12,394 shares at USD 9.88.
- Directly held common shares fell to 39,900.
- Directly held stock options rose to 83,848.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001810417-26-000023), on September 18, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Big iron ore miners deplete reserves faster than they replace
Mining.com•2026/09/18 23:45
The Federal Reserve signals continued interest rate hikes; the U.S. dollar posts its largest single-week gain in over three months.
After the Federal Reserve signaled continued interest rate hikes in the future, the US dollar strengthened significantly this week, marking its largest single-week gain in more than three months.
智通财经•2026/09/18 23:31
South Korean Won: Foreign equity flows keep KRW heavy against US Dollar – OCBC
FXStreet•2026/09/18 23:30
